(833) 317-6278 
— In trial, datopotamab deruxtecan increased progression-free survival by 2 months
Mike Bassett
Geo Focus
Coverage Attributes:
Beta
Cites Data:
69
%
Press Release:
13
%
Expert Commentary:
10
%
Opinion Editorial:
4
%
Government Announcement:
2
%
Themes Covered:
Not enough data
Pitching Insights
Mike Bassett's articles predominantly focus on healthcare and pharmaceuticals, with a particular emphasis on cancer research, medical treatments, clinical trials, and oncology. His coverage heavily relies on data citations.
When reaching out to Mike Bassett, consider providing data-driven insights or expert commentary related to the latest developments in cancer research and medical treatments. Pitches should be backed by credible data sources and provide valuable analysis or interpretation of scientific findings within these areas of interest.
Given his broad spectrum of topics covered under healthcare & pharmaceuticals, pitches must offer unique perspectives supported by reliable scientific evidence or recent breakthroughs in the field.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Journalists With Similar Coverage:
Based on similarity of content.
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
